{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:11Z","timestamp":1787498651426,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":1829,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA 91846; to XW"],"award-info":[{"award-number":["P50 CA 91846; to XW"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Translational and Public Health Genomics at MD Anderson Cancer Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1093\/ajcn\/nqx019","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T15:28:51Z","timestamp":1519658931000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Is folic acid safe for non\u2013muscle-invasive bladder cancer patients? An evidence-based cohort study"],"prefix":"10.1016","volume":"107","author":[{"given":"Huakang","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Barton","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth P","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/nqx019_bib1","article-title":"Cancer facts & figures 2016","year":"2016","journal-title":"Cancer facts & figures 2016"},{"key":"10.1093\/ajcn\/nqx019_bib2","series-title":"Bladder tumors: molecular aspects and clinical management.","author":"Vinata","year":"2010"},{"key":"10.1093\/ajcn\/nqx019_bib3","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1093\/ajcn\/nqx019_bib4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1476-069X-11-S1-S11","article-title":"Bladder cancer, a review of the environmental risk factors","volume":"11","author":"Letasiova","year":"2012","journal-title":"Environ Health"},{"key":"10.1093\/ajcn\/nqx019_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1093\/ajcn\/nqx019_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance bacillus Calmette-Guerin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1093\/ajcn\/nqx019_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/bjc.1993.147","article-title":"The clinical epidemiology of superficial bladder cancer","volume":"67","author":"Kiemeney","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib11","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1093\/ajcn\/nqx019_bib12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"key":"10.1093\/ajcn\/nqx019_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrc1144","article-title":"Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms","volume":"3","author":"Lamprecht","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jn\/130.2.129","article-title":"Folate and carcinogenesis: an integrated scheme","volume":"130","author":"Choi","year":"2000","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib16","first-page":"8781","article-title":"Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid: final rule","volume":"61","year":"1996","journal-title":"Fed Regist"},{"key":"10.1093\/ajcn\/nqx019_bib17","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1001\/jama.2009.1691","article-title":"Assessing cancer prevention studies\u2014a matter of time","volume":"302","author":"Drake","year":"2009","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/nqx019_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu3030370","article-title":"Folic acid food fortification\u2014its history, effect, concerns, and future directions","volume":"3","author":"Crider","year":"2011","journal-title":"Nutrients"},{"key":"10.1093\/ajcn\/nqx019_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/aje\/kwh207","article-title":"Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"160","author":"Radimer","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1055-9965.EPI-06-0054","article-title":"Folate supplementation: too much of a good thing?","volume":"15","author":"Ulrich","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/ajcn\/nqx019_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in dietary supplement use among US adults from 1999\u20132012","volume":"316","author":"Kantor","year":"2016","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/nqx019_bib22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1093\/ajcn\/nqx019_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajcn\/82.2.442","article-title":"Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999\u20132000","volume":"82","author":"Pfeiffer","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1200\/JCO.2007.13.5905","article-title":"Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review","volume":"26","author":"Velicer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/ajcn\/nqx019_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/em.20025","article-title":"Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies","volume":"44","author":"Kim","year":"2004","journal-title":"Environ Mol Mutagen"},{"key":"10.1093\/ajcn\/nqx019_bib26","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(06)68582-6","article-title":"Folic acid: a public-health challenge","volume":"367","author":"Eichholzer","year":"2006","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/nqx019_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ajcn\/87.3.517","article-title":"Is folic acid good for everyone?","volume":"87","author":"Smith","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ajcn\/86.2.271","article-title":"Folate and cancer prevention: a closer look at a complex picture","volume":"86","author":"Ulrich","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ajcn\/80.5.1123","article-title":"Will mandatory folic acid fortification prevent or promote cancer?","volume":"80","author":"Kim","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib30","doi-asserted-by":"crossref","first-page":"3731S","DOI":"10.1093\/jn\/133.11.3731S","article-title":"Role of folate in colon cancer development and progression","volume":"133","author":"Kim","year":"2003","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1301\/nr.2007.nov.504-511","article-title":"Folic acid fortification and supplementation\u2013good for some but not so good for others","volume":"65","author":"Kim","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1093\/ajcn\/nqx019_bib32","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1001\/jama.297.21.2408","article-title":"Folate and cancer\u2014timing is everything","volume":"297","author":"Ulrich","year":"2007","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/nqx019_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/gut.2006.095463","article-title":"Folate: a magic bullet or a double edged sword for colorectal cancer prevention?","volume":"55","author":"Kim","year":"2006","journal-title":"Gut"},{"key":"10.1093\/ajcn\/nqx019_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.329.7479.1375","article-title":"Taking folate in pregnancy and risk of maternal breast cancer","volume":"329","author":"Charles","year":"2004","journal-title":"BMJ"},{"key":"10.1093\/ajcn\/nqx019_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/jnci\/djp019","article-title":"Folic acid and risk of prostate cancer: results from a randomized clinical trial","volume":"101","author":"Figueiredo","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/ajcn\/nqx019_bib36","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","article-title":"Folic acid for the prevention of colorectal adenomas: a randomized clinical trial","volume":"297","author":"Cole","year":"2007","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/nqx019_bib37","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2009.1622","article-title":"Cancer incidence and mortality after treatment with folic acid and vitamin B12","volume":"302","author":"Ebbing","year":"2009","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/nqx019_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(12)62001-7","article-title":"Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals","volume":"381","author":"Vollset","year":"2013","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/nqx019_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/clinchem\/16.5.375","article-title":"Urinary excretion of folic acid activity in man","volume":"16","author":"Cooperman","year":"1970","journal-title":"Clin Chem"},{"key":"10.1093\/ajcn\/nqx019_bib40","series-title":"Handbook of vitamins.","author":"Zempleni","year":"2013"},{"key":"10.1093\/ajcn\/nqx019_bib41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1093\/ajcn\/nqx019_bib42","doi-asserted-by":"crossref","first-page":"e21820","DOI":"10.1371\/journal.pone.0021820","article-title":"Expression of RFC\/SLC19A1 is associated with tumor type in bladder cancer patients","volume":"6","author":"Abdel-Haleem","year":"2011","journal-title":"PLoS One"},{"key":"10.1093\/ajcn\/nqx019_bib43","first-page":"1260419","article-title":"Proteomics: t","volume":"347","author":"Uhlen","year":"2015","journal-title":"issue-based map of the human proteome"},{"key":"10.1093\/ajcn\/nqx019_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1940-6207.CAPR-10-0035","article-title":"Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer","volume":"3","author":"Chen","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1093\/ajcn\/nqx019_bib45","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1200\/JCO.2005.01.598","article-title":"Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival","volume":"23","author":"Leibovici","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/ajcn\/nqx019_bib46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib48","doi-asserted-by":"crossref","first-page":"26760","DOI":"10.1038\/srep26760","article-title":"Different dietary patterns and reduction of lung cancer risk: a large case-control study in the U.S","volume":"6","author":"Tu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1093\/ajcn\/nqx019_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1207\/s15327914nc5302_3","article-title":"Case-control analysis of dietary folate and risk of bladder cancer","volume":"53","author":"Schabath","year":"2005","journal-title":"Nutr Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib50","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/oxfordjournals.aje.a116965","article-title":"Revision of dietary analysis software for the Health Habits and History Questionnaire","volume":"139","author":"Block","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oxfordjournals.aje.a114416","article-title":"A data-based approach to diet questionnaire design and testing","volume":"124","author":"Block","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-8223(21)00707-0","article-title":"Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period","volume":"92","author":"Block","year":"1992","journal-title":"J Am Diet Assoc"},{"key":"10.1093\/ajcn\/nqx019_bib53","article-title":"Agricultural Research Service, US Department of Agriculture","year":"2014","journal-title":"USDA National Nutrient Database for Standard Reference, Release 27"},{"key":"10.1093\/ajcn\/nqx019_bib54","article-title":"USDA Food and Nutrient Database for Dietary Studies, 4.1","year":"2010","journal-title":"USDA Food and Nutrient Database for Dietary Studies, 4.1"},{"key":"10.1093\/ajcn\/nqx019_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.aje.a114366","article-title":"Total energy intake: implications for epidemiologic analyses","volume":"124","author":"Willett","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2011.04.004","article-title":"High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer","volume":"141","author":"Stevens","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1093\/ajcn\/nqx019_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/oxfordjournals.aje.a008955","article-title":"Nutrient intake in relation to bladder cancer among middle-aged men and women","volume":"144","author":"Bruemmer","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib58","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1054\/bjoc.2001.1968","article-title":"Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study","volume":"85","author":"Zeegers","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib59","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/bjc.2012.187","article-title":"Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States","volume":"106","author":"Wu","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1207\/s15327914nc5302_3","article-title":"Case-control analysis of dietary folate and risk of bladder cancer","volume":"53","author":"Schabath","year":"2005","journal-title":"Nutr Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib61","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2009.06.030","article-title":"Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort","volume":"56","author":"Roswall","year":"2009","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib62","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3945\/jn.113.174920","article-title":"Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study","volume":"143","author":"Park","year":"2013","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib63","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/aje\/152.12.1145","article-title":"Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men","volume":"152","author":"Michaud","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1093\/ajcn\/nqx019_bib64","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/sj.bjc.6600604","article-title":"Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study","volume":"87","author":"Michaud","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.juro.2010.11.081","article-title":"Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle Study","volume":"185","author":"Hotaling","year":"2011","journal-title":"J Urol"},{"key":"10.1093\/ajcn\/nqx019_bib66","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10552-005-0337-z","article-title":"Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States)","volume":"16","author":"Holick","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1093\/ajcn\/nqx019_bib67","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ejca.2007.05.007","article-title":"Food, nutrient and heterocyclic amine intake and the risk of bladder cancer","volume":"43","author":"Garc\u00eda-Closas","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10552-009-9490-0","article-title":"Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study","volume":"21","author":"Brinkman","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1093\/ajcn\/nqx019_bib69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/annonc\/mdq356","article-title":"Dietary folate intake and the risk of 11 types of cancer: a case-control study in Uruguay","volume":"22","author":"Aune","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/ajcn\/nqx019_bib70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09637486.2013.866641","article-title":"Folate intake and risk of bladder cancer: a meta-analysis of epidemiological studies","volume":"65","author":"He","year":"2014","journal-title":"Int J Food Sci Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib71","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/jn\/127.12.2321","article-title":"A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability in humans: evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2]folic acid","volume":"127","author":"Rogers","year":"1997","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib72","doi-asserted-by":"crossref","first-page":"15424","DOI":"10.1073\/pnas.0902072106","article-title":"The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake","volume":"106","author":"Bailey","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/ajcn\/nqx019_bib73","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"10.1093\/ajcn\/nqx019_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jnutbio.2015.12.006","article-title":"High folic acid intake reduces natural killer cell cytotoxicity in aged mice","volume":"30","author":"Sawaengsri","year":"2016","journal-title":"J Nutr Biochem"},{"key":"10.1093\/ajcn\/nqx019_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jn\/136.1.189","article-title":"Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women","volume":"136","author":"Troen","year":"2006","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/nqx019_bib77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1055-9965.511.13.4","article-title":"Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer?","volume":"13","author":"Kim","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/ajcn\/nqx019_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1093\/ajcn\/nqx019_bib79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1093\/ajcn\/nqx019_bib80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.eursup.2009.06.010","article-title":"Recurrence, progression, and follow-up in non\u2013muscle-invasive bladder cancer","volume":"8","author":"van der Heijden","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1093\/ajcn\/nqx019_bib81","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1093\/ajcn\/nqx019_bib82","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1093\/ajcn\/nqx019_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ncpuro1061","article-title":"Why should we increase public awareness of bladder cancer, and how can we do it?","volume":"5","author":"Messing","year":"2008","journal-title":"Nat Clin Pract Urol"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522027678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916522027678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/107\/2\/208\/29157893\/nqx019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T12:27:09Z","timestamp":1685104029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916522027678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0002916522027678"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/nqx019","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is folic acid safe for non\u2013muscle-invasive bladder cancer patients? An evidence-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/nqx019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}